Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporatio...( Company extends the term and expands ...),Health

Company extends the term and expands territorial rights of its exclusive licensee in Japan after Itochu reaches market penetration milestone of 100 customer manufacturers in Japan for cosmeceutical and dietary supplement products using patented AC-11(R) (formerly known as C-Med- 100(R))

Increase in consumer demand fueled by results of new research showing that that orally administered AC-11(R) supplement increases the production of collagen III in the epidermis layer of the skin.

NEW YORK, April 6 /PRNewswire-FirstCall/ -- Optigenex Inc. (Pink Sheets: OPGX) announced today the signing of an extended and expanded new contract with its distribution partner in Asia (Itochu Corporation). Under the new license, Itochu has the right to market AC-11(R) technology exclusively in Japan and non-exclusively throughout the rest of Asia (Additional details were not disclosed). The new agreement represents the fulfillment of an important strategic objective to the company in terms of its business development plans for the Asia and further validates its business model in Japan and other countries in the region.

To date, Itochu has introduced AC-11(R) to over 100 companies in the cosmetic and dietary supplement market, with over 130 products containing AC-11(R) being marketed and sold. AC-11(R) is a patented, all-natural rain forest botanical extract that helps the body's natural ability to repair damage to its own DNA due to multiple causes, including harmful effects of UV radiation from over exposure to the sun, stress, environmental pollution and other toxins. In its standard bulk powder form, AC-11(R) supplement may be consumed orally or combined with liposomes and other delivery mechanisms for topical application on the skin.

The increase in demand for AC-11(R)-based products follows the issuance of a report in October 2008 by a leading French dermatological research center showing that orally a
'/>"/>